PILOT PROGRAM TO ASSIST CERTAIN MEMBERS OF THE ARMED FORCES AND DEPENDENTS WITH ADDITIONAL SUPPLEMENTAL COVERAGE RELATING TO CANCER HT9402-26-RFI-0255

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT9402-26-RFI-0255

NAICS

524114 - Direct Health and Medical Insurance Carriers

Classification Code

Q201

Additional Details
Set Aside

NONE

Place of Performance

Aurora, Colorado, UNITED STATES

SourceSAM
Documents4
The Defense Health Agency (DHA), under the Department of Defense, has issued a Special Notice (HT9402-26-RFI-0255) to conduct market research for a pilot program aimed at providing supplemental cancer insurance coverage to certain members of the Armed Forces and their dependents. This initiative is mandated by Section 734 of the National Defense Authorization Act (NDAA) for Fiscal Year 2026, which requires the establishment of a pilot program by September 30, 2027. The program targets regular component members of the Army, Navy, Marine Corps, Air Force, and Space Force, as well as their dependents enrolled in TRICARE, to address noncovered expenses related to cancer screening, diagnosis, and treatment. **Purpose and Scope** The primary objective of this procurement activity is to assess the feasibility and value of offering a no-cost, fixed indemnity supplemental cancer insurance plan to eligible TRICARE beneficiaries. The intent is to reduce the financial burden associated with cancer care, support beneficiary wellness, enhance family resilience, and maintain force readiness in the event of a cancer diagnosis. The pilot will inform future policy decisions regarding supplemental benefits for military families. **Key Requirements and Objectives** The DHA is seeking industry feedback on the design and implementation of a TRICARE-specific supplemental cancer insurance plan. Respondents are expected to address a comprehensive set of questions covering: - **Plan Differentiation:** How a TRICARE-specific plan would differ from existing commercial offerings, including coverage of non-TRICARE services and portability options. - **Coverage Details:** Scope of coverage, exclusions, benefit caps, coverage for experimental treatments, pre-existing conditions, and geographic availability (including overseas). - **Eligibility and Enrollment:** Financial viability of an unsubsidized, 100% beneficiary-paid group plan, eligibility verification, enrollment processes, premium structures, and termination procedures. - **Claims and Payments:** Claims processing, payment structures (lump sum or recurring), tax implications, digital tools for claims management, and third-party liability considerations. - **Reporting and Oversight:** Data sharing with the government, recommended metrics for program evaluation, industry oversight standards, and privacy protections. - **Qualifications:** Company experience in supplemental insurance, claims acceptance/denial rates, and data security measures. - **Acquisition Strategy:** Approaches to participating in a “no-cost” contract and anticipated barriers to participation. **Expected Deliverables** Interested vendors are required to submit a written response (not exceeding 20 pages) that specifically addresses the topics outlined in the RFI. General capability statements are discouraged; instead, responses should provide detailed, tailored information relevant to the pilot program’s objectives. Presentation materials for scheduled one-on-one virtual meetings must be submitted one business day prior to the event. **Contracting Entity and Contact Information** - **Contracting Entity:** Defense Health Agency (DHA), Managed Care Contracting Division - **Location:** Aurora, Colorado, United States (NAICS Code: 524114 – Direct Health and Medical Insurance Carriers; PSC: Q201) - **Primary Contact:** Marcus R. Webb ([email protected], 303-676-3451) - **Secondary Contact:** James Goddard ([email protected], 303-676-3671) **Procurement Type and Special Considerations** This notice is a Request for Information (RFI) and does not constitute a solicitation or a commitment to contract. There is no set-aside for this opportunity. The RFI is issued solely for planning and market research purposes; the government will not reimburse any costs incurred in responding. All responses may be subject to public release under the Freedom of Information Act (FOIA) unless appropriately marked. No proprietary, classified, or sensitive information should be included in submissions. **Additional Information and Timeline** - **Virtual Industry Meetings:** Scheduled for November 17 and 19, 2026, to facilitate one-on-one discussions with interested vendors. - **Response Deadline:** Written responses are due by close of business on September 18, 2026. - **Attachments:** Additional information, including Q&A and presentation guidance, is available in the attachments section of the notice. **Constant Elements Over Contract Lifecycle** - The pilot program is mandated by federal law and will focus on TRICARE-eligible active duty service members and their dependents. - The program’s core aim is to provide supplemental financial protection for cancer-related expenses not covered by existing TRICARE benefits. - The DHA will use industry feedback to shape the pilot’s design, implementation, and potential future expansion. **Conclusion** This RFI represents a significant opportunity for insurance carriers with experience in supplemental health coverage to contribute to a high-impact pilot program serving military families. Interested parties should carefully review the detailed requirements and objectives, and ensure their responses are tailored to the unique needs of the TRICARE population. For further information or to schedule a meeting, vendors are encouraged to contact the designated DHA representatives.